Find, compare & contact
Caffeine API Manufacturers & Suppliers

Looking for Caffeine API 58-08-2?

Description:

Here you will find a list of producers, manufacturers and distributors of Caffeine. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Caffeine 

Synonyms:

Anhydrous caffeine , Caffeine , Coffein , Guaranine , Koffein , Methyltheobromine , Teina , Thein , Theine , Coffeinum  

Cas Number:

58-08-2 

DrugBank number:

DB00201 

Unique Ingredient Identifier:

3G6A5W338E

Caffeine is a type of Central Nervous System Agents

Central Nervous System (CNS) Agents are a crucial category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that specifically target the central nervous system. The CNS encompasses the brain and spinal cord, playing a vital role in regulating and controlling various bodily functions, including cognition, movement, emotions, and sensory perception. These agents are designed to interact with specific receptors, enzymes, or ion channels within the CNS to modulate neural activity and restore normal functioning.

CNS agents comprise a diverse range of pharmaceutical APIs, including analgesics, anesthetics, antipsychotics, sedatives, hypnotics, anti-epileptics, and antidepressants. Each subcategory addresses distinct neurological disorders and conditions. For instance, analgesics alleviate pain by targeting receptors in the brain and spinal cord, while antipsychotics are employed to manage psychosis symptoms in mental illnesses such as schizophrenia.

The development of CNS agents involves rigorous research, molecular modeling, and extensive clinical trials to ensure safety, efficacy, and specific target engagement. Pharmaceutical companies invest significant resources in identifying novel drug targets, synthesizing new compounds, and optimizing their pharmacological properties. These agents undergo rigorous regulatory evaluations and must adhere to stringent quality standards and guidelines.

Given the prevalence of CNS disorders globally, the market demand for effective CNS agents is substantial. The development of innovative CNS APIs not only improves patient outcomes but also provides valuable commercial opportunities for pharmaceutical companies. Continued advancements in CNS agent research and development hold the promise of groundbreaking therapies that can improve the quality of life for individuals affected by neurological conditions.

• Pharm Rx Chemical Corp from United States, product country of origin China
• Rochem International, Inc. from United States, product country of origin United States
• Caesar & Loretz GmbH (CAELO) from Germany, product country of origin Germany
• Duchefa Farma B.V. from Netherlands, product country of origin Germany
• Shizuoka Coffein Co from Japan, product country of origin Japan
• Aquatic Remedies Pvt Ltd from India, product country of origin India
• Kudos Chemie from India, product country of origin India
• Hachidai Pharmaceutical from Japan, product country of origin Japan
• CSPC Innovation from China, product country of origin China
• Shandong Xinhua from China, product country of origin China
• Shiratori Pharmaceutical from Japan, product country of origin Japan
• Siegfried from Germany, product country of origin Unknown
• Indukern Chemie AG from Switzerland, product country of origin Unknown

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.